Table 1 Comparison of clinical characteristics between the two groups
Clinical characteristics | Groups | P value | |
|---|---|---|---|
Non-energy device (n=96) | Energy device (n=92) | ||
Age (years) | 60.55±9.82 | 60.84±9.32 | 0.839 |
Gender | |||
Male | 58 (30.85%) | 61 (32.45%) | 0.450 |
Female | 38 (20.21%) | 31 (16.49%) | |
BMI | 22.92±3.12 | 23.39±3.57 | 0.347 |
FEV1 | 2.36±0.58 | 2.27±0.66 | 0.384 |
Location of primary | |||
Peripheral | 80 (42.55%) | 69 (36.70%) | 0.208 |
Central | 16 (8.51%) | 23 (12.23%) | |
Lobar origin | |||
RUL | 19 (10.11%) | 32 (17.02%) | 0.277 |
RML | 12 (6.38%) | 5 (2.66%) | |
RLL | 16 (8.51%) | 14 (7.45%) | |
RMLL | 0 (0%) | 2 (1.06%) | |
Right hilum | 1 (0.53%) | 2 (1.06%) | |
LUL | 33 (17.55%) | 18 (9.57%) | |
LLL | 15 (7.98%) | 16 (8.51%) | |
Left hilum | 0 (0%) | 3 (1.60%) | |
pTNM stage | |||
IA | 35 (18.62%) | 17 (9.04%) | 0.084 |
IB | 19 (10.11%) | 26 (13.83%) | |
IIA | 5 (2.66%) | 6 (3.19%) | |
IIB | 14 (7.45%) | 13 (6.91%) | |
IIIA | 15 (7.98%) | 19 (10.11%) | |
IIIB | 2 (1.06%) | 9 (4.79%) | |
IIIC | 1 (0.53%) | 0 (0%) | |
IVA | 4 (2.13%) | 3 (1.60%) | |
Mean tumor diameter (cm) | 3.21±1.92 | 3.30±1.45 | 0.736 |
Operative time (min) | 154.98±43.07 | 172.83±44.96 | 0.006 |
Blood loss (ml) | 216.76±148.06 | 188.37±105.70 | 0.133 |
Chest tube drainage (ml) | 117.62±51.34 | 104.86±50.29 | 0.352 |
Duration with tube (day) | 5.49±3.82 | 3.97±3.27 | 0.531 |
RLNI | 12 (6.38%) | 25 (13.30%) | 0.016 |